comparemela.com

Latest Breaking News On - Amicus therapeutics - Page 13 : comparemela.com

Jump Financial LLC Has $2 89 Million Stock Position in Amicus Therapeutics, Inc (NASDAQ:FOLD)

Jump Financial LLC Has $2 89 Million Stock Position in Amicus Therapeutics, Inc (NASDAQ:FOLD)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Brokerages Set Amicus Therapeutics, Inc (NASDAQ:FOLD) Target Price at $17 20

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year target price among analysts […]

John F Crowley Sells 55,327 Shares of Amicus Therapeutics, Inc (NASDAQ:FOLD) Stock

John F Crowley Sells 55,327 Shares of Amicus Therapeutics, Inc (NASDAQ:FOLD) Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Q3 2024 EPS Estimates for Amicus Therapeutics, Inc Cut by Analyst (NASDAQ:FOLD)

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) – Zacks Research decreased their Q3 2024 earnings estimates for shares of Amicus Therapeutics in a report issued on Thursday, January 18th. Zacks Research analyst R. Department now forecasts that the biopharmaceutical company will earn $0.00 per share for the quarter, down from their prior estimate of $0.01. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.